Viatris Inc.
USD16.23
-0.10 (-0.61%)
CEO
Scott Andrew Smith
IPO Date
1980-03-17
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$16.33
Prev. Close
$16.33
Day Low
$16.21
Day High
$16.52
52W Low
$8.63
52W High
$17.53
Market Cap
$18.90B
Volume
8.91M
| -23.4 |
| 31 Dec 2023 | FY | 41.7% | 0.4% | 0.3% | 0.1% | 0.90 | 1.67 | 237.6 |
| 31 Dec 2022 | FY | 40.0% | 12.8% | 9.9% | 4.2% | 0.93 | 1.58 | 6.5 |
| 31 Dec 2021 | FY | 31.2% | -7.1% | -6.2% | -2.3% | 1.14 | 1.10 | -12.9 |
| 31 Dec 2020 | FY | 31.8% | -5.6% | -2.9% | -1.1% | 1.14 | 1.22 | -16.8 |
| 31 Dec 2019 | FY | 33.9% | 0.1% | 0.1% | 0.1% | 1.09 | 1.21 | 670.0 |
| 30 Dec 2018 | FY | 35.0% | 3.1% | 2.9% | 1.1% | 1.14 | 1.39 | 40.1 |
| 30 Dec 2017 | FY | 40.2% | 5.8% | 5.2% | 1.9% | 1.10 | 1.13 | 32.5 |
| 30 Dec 2016 | FY | 42.4% | 4.3% | 4.3% | 1.4% | 1.39 | 1.49 | 41.4 |
| -10.5 |
| 30 Sept 2025 | Q3 | 36.8% | -3.4% | -0.8% | -0.3% | 0.97 | 1.35 | -22.5 |
| 30 Jun 2025 | Q2 | 37.2% | -0.1% | -0.0% | -0.0% | 0.95 | 1.37 | -569.3 |
| 31 Mar 2025 | Q1 | 35.7% | -93.5% | -19.4% | -7.9% | 0.92 | 1.68 | -0.9 |
| 31 Dec 2024 | Q4 | 34.4% | -14.6% | -2.8% | -1.2% | 0.77 | 1.65 | -7.2 |
| 30 Sept 2024 | Q3 | 38.9% | 2.5% | 0.5% | 0.2% | 0.81 | 1.51 | 36.5 |
| 30 Jun 2024 | Q2 | 38.1% | -8.6% | -1.7% | -0.7% | 0.89 | 1.53 | -9.7 |
| 31 Mar 2024 | Q1 | 41.1% | 3.1% | 0.6% | 0.2% | 0.91 | 1.67 | 31.3 |
| 31 Dec 2023 | Q4 | 41.6% | -20.0% | -3.7% | -1.6% | 0.90 | 1.67 | -4.2 |